Brolucizumab

Red

Brand Name(s):

Indication:Wet age – related macular degeneration

Rationale:1,2,8

Considered:Feb-21

Review Date:Feb-26

Comments:
Brolucizumab is recommended as an option for treating wet age-related macular degeneration in adults, under certain clinical criteria only